Insights

The Renergen (ASX:RLT) share price is surging 13%. Here’s why

The Renergen share price is rocketing today, up 15% in early afternoon trade. We look at what’s driving ASX investor interest.
The post The Renergen (ASX:RLT) share price is surging 13%. Here’s why appeared first on The Motley Fool Australia. –

man jumps up a chart, indicating share price going up on the ASX bank dividend

The Renergen Limited (ASX: RLT) share price is gaining strongly today, up 13.21% in afternoon trade.

The soaring share price appears to be driven by the helium and natural gas company’s ASX release yesterday, after markets closed, announcing the completion and successful operation of its first Cryo-Vacc prototype.

Why is Renergen’s Cryo-Vacc launch driving ASX investor interest?

The spike in investor interest in the company’s Cryo-Vacc prototype is likely linked to its potential role in delivering COVID-19 vaccines, particularly in developing nations where reliable cold storage facilities are few and far between.

Renergen delivered the prototype to South African-based media in Johannesburg yesterday. The company plans to start production within days.

According to Renergen’s release, Cryo-Vacc enables the “efficient transport and storage of ultracold biologics for periods of up to 25 days or longer in transit”. This is possible even when there is no external power available. The unit can maintain temperatures in the range of anywhere from -150 ºC to 8ºC, enabling it to support the delivery of a suite of vaccines.

Cryo-Vacc units are also able to give accurate temperature readings of the vaccines during transit, along with GPS tracking.

The units use liquid nitrogen to transport by road and helium to transport by air. Helium is far lighter than nitrogen, and Renergen reported that based on current flight safety regulations, Cryo-Vacc with helium can transport up to 12 times more vials per flight “compared to other cryogens”.

In South Africa, Renergen has partnered with local express courier partner, DPD Laser, part of The Laser Group, to distribute vaccines.

Commenting on the rollout of the company’s Cryo-Vacc, Renergen’s CEO Stefano Marani:

Precise temperature control combined with a formidable hold time in transit, makes Cryo-Vacc a compelling asset in the transport of biologics, especially in the developing world. With a useful temperature range of over 150 ºC, Cryo-Vacc is very versatile when compared to even standard refrigeration technology.

Following the presentation to South African media, Marani added (quoted by Reuters), “We’ve already started to take orders for this product. So we’re ready to start going into production in the next few days.”

He added that Renergen has already received numerous queries and order requests from across the globe.

Renergen share price snapshot

With today’s intraday gains taken into account, the Renergen share price is up 45% so far in 2021. That compares to a gain of 3% on the All Ordinaries Index (ASX: XAO).

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

See The 5 Stocks

*Returns as of February 15th 2021

More reading

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post The Renergen (ASX:RLT) share price is surging 13%. Here’s why appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!